Abstract
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting. Copyright © 2011 by Lippincott Williams & Wilkins.
Author supplied keywords
Cite
CITATION STYLE
Al-Dabbagh, M., Lapphra, K., McGloin, R., Inrig, K., Schaaf, H. S., Marais, B. J., … Kollmann, T. R. (2011). Drug-resistant tuberculosis: Pediatric guidelines. Pediatric Infectious Disease Journal, 30(6), 501–505. https://doi.org/10.1097/INF.0b013e31820b583d
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.